Alumis (ALMS) Net Income Growth (1y) (2024 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.59%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -115.33%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -73.01%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 Alumis 1.84 Bn 1.75 Bn - 1.89%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.89%
Sep 30, 2025 -18.94%
Jun 30, 2025 204.98%
Mar 31, 2025 -113.33%
Dec 31, 2024 -136.12%
Sep 30, 2024 -112.80%
Jun 30, 2024 -53.93%